Zolat (40mg) 1 Injection/Infusion
Zolat 40mg Injection/Infusion contains omeprazole, a proton pump inhibitor used when oral acid-suppressing therapy is unsuitable for conditions such as gastric ulcer, duodenal ulcer, reflux oesophagitis and Zollinger-Ellison syndrome.
₨ 328
Overview
Zolat 40mg Injection/Infusion is an injectable acid-suppressing medicine containing omeprazole 40mg. Omeprazole belongs to the proton pump inhibitor class and is used in hospital or clinical settings when a patient needs short-term gastric acid control but oral treatment is not appropriate. It may be used for acid-related disorders such as gastric ulcer, duodenal ulcer, reflux oesophagitis, and conditions associated with excessive acid secretion, including Zollinger-Ellison syndrome.
This product is intended for administration by a qualified healthcare professional. Because it is supplied as an injection or infusion product, correct reconstitution, dilution, compatibility checks and administration technique are essential for safety and effectiveness.
Benefits
- Reduces gastric acid production
- Supports treatment of acid-related gastric and duodenal ulcer conditions
- Useful when oral acid-suppressing medicine cannot be used
- May help manage reflux oesophagitis and hypersecretory acid conditions under medical care
Key Features
- Omeprazole 40mg injectable/infusion medicine
- Proton pump inhibitor for gastric acid suppression
- Used under medical supervision when oral therapy is not appropriate
- Single-vial pack format
- Anti-ulcerant therapeutic category
Dosage and How to Use
- How to use: For intravenous injection or infusion only, prepared and administered by a qualified healthcare professional according to clinical protocol and product instructions.
- Administration: Intravenous injection or infusion by trained healthcare personnel only. Not for self-administration.
- Recommended dose: Dose must be prescribed by a doctor. A commonly used adult dose for many acid-related indications is 40mg once daily when oral therapy is inappropriate, but dosing may vary by condition and patient response.
- Adult dose: Commonly 40mg once daily when oral therapy is not suitable, unless the prescriber recommends a different regimen.
- Pediatric use: Limited pediatric use should be guided by a qualified healthcare professional. Do not use in children unless prescribed.
- Elderly use: Dose adjustment is generally not required solely because of age, but elderly patients should use it under medical supervision with attention to overall health and other medicines.
- When to take: Administer at the time and frequency prescribed by the doctor. Timing may depend on the clinical condition and treatment plan.
- With food: Food timing is usually not relevant for intravenous administration, but follow the prescriber’s instructions.
- Maximum daily dose: Do not exceed the dose prescribed by the doctor. Higher doses for hypersecretory conditions require specialist supervision.
- Missed dose: Because this medicine is administered by healthcare professionals, missed doses should be handled by the treating doctor or nurse. Do not double a dose without medical advice.
- Overdose: In case of suspected overdose or accidental administration error, seek urgent medical attention and provide the medicine details to healthcare staff.
Specifications
| Brand | Zolat |
|---|---|
| Marketer / Distributor | English Pharma |
| Country of Origin | Pakistan |
| Drug class | Proton pump inhibitor |
| Therapeutic category | Anti-ulcerant / gastric acid suppression therapy |
| Age group | Use as prescribed; adult use is common. Pediatric use should be determined by a specialist. |
| Suitable for | Patients who require omeprazole therapy and cannot use oral treatment, as determined by a healthcare professional. |
| Prescription required | Yes |
Side Effects
Common side effects
- Headache
- Abdominal pain
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Flatulence
- Dizziness
Serious side effects (seek medical help)
- Severe allergic reaction
- Severe or persistent diarrhoea
- Severe skin reaction
- Signs of liver problems such as yellowing of skin or eyes
- Symptoms of low magnesium during prolonged use such as seizures, irregular heartbeat or muscle spasms
Allergic reaction
Seek urgent help if signs of allergy occur, including rash, itching, swelling of the face or throat, severe dizziness, wheezing or difficulty breathing.
Safety and Precautions
- Use only on prescription and under medical supervision.
- Do not use if allergic to omeprazole, other proton pump inhibitors or substituted benzimidazoles.
- Tell your doctor about alarm symptoms such as unexplained weight loss, vomiting blood, black stools or difficulty swallowing.
- Longer-term proton pump inhibitor use may require monitoring for low magnesium, vitamin B12 deficiency, bone fracture risk or gastrointestinal infections.
- Inform the doctor about liver disease, kidney problems, pregnancy, breastfeeding and all current medicines.
- Review the need for injectable therapy regularly and switch to oral treatment when clinically appropriate.
- Do not mix or administer with other products unless compatibility is confirmed.
When not to use
Do not use if the patient has a known allergy to omeprazole or related proton pump inhibitors. Do not use without a valid medical prescription.
Special populations
- Pregnancy: Use during pregnancy only if prescribed by a healthcare professional after assessing benefit and risk.
- Breastfeeding: Consult a doctor before use while breastfeeding. The prescriber should decide whether treatment is appropriate.
- Fertility: No product-specific fertility guidance is confirmed for this listing. Discuss concerns with a healthcare professional.
- Liver: Use with medical supervision in patients with liver disease; dose adjustment or monitoring may be required depending on clinical status.
- Kidney: Use under medical advice in patients with kidney disease, especially if symptoms change or other medicines are being used.
- Heart: Patients with heart disease or those taking medicines such as clopidogrel, warfarin or digoxin should inform their doctor before treatment.
- Driving: Omeprazole is not expected to impair driving in most patients, but dizziness or visual disturbance may occur. Do not drive or operate machinery if affected.
- Alcohol: Alcohol may worsen gastric irritation or reflux symptoms. Follow medical advice and avoid alcohol if it aggravates symptoms.
Interactions
Drugs:
- Clopidogrel
- Warfarin
- Diazepam
- Phenytoin
- Digoxin
- Methotrexate
- Tacrolimus
- Certain antifungal medicines such as ketoconazole or itraconazole
- Certain HIV medicines
- Medicines affected by stomach acidity or CYP2C19 metabolism
Food:
- No major food interaction is expected with intravenous administration, but diet may influence reflux or ulcer symptoms. Follow the clinician’s dietary advice.
Conditions:
- Liver disease
- Suspected gastric malignancy or alarm gastrointestinal symptoms
- History of low magnesium with prolonged acid suppression
- Osteoporosis or high fracture risk with long-term proton pump inhibitor use
Storage and Disposal
- Store in the original packaging according to the label instructions. Protect from excessive heat, light and moisture. Use prepared solution within the recommended period set by product information or facility protocol.
- Follow the storage temperature stated on the product label; do not freeze unless specifically instructed.
- Keep out of the reach and sight of children.
- Dispose of unused medicine, vials, needles and clinical waste according to hospital, pharmacy or local healthcare waste procedures.
Disclaimer
This information is for educational and product listing purposes only and is not a substitute for professional medical advice. Use only as prescribed and administered by qualified healthcare professionals. Consult a doctor or pharmacist for diagnosis, dosing, interactions, pregnancy or breastfeeding advice, side effects or emergencies.
| Introduction Of Product | Zolat 40mg Injection/Infusion contains omeprazole 40mg, a proton pump inhibitor used for acid-related gastrointestinal conditions when oral treatment is unsuitable. |
|---|---|
| Key Features | Omeprazole 40mg injectable/infusion medicine, Proton pump inhibitor for gastric acid suppression, Used under medical supervision when oral therapy is not appropriate, Single-vial pack format, Anti-ulcerant therapeutic category |
| Key Benefits | Reduces gastric acid production, Supports treatment of acid-related gastric and duodenal ulcer conditions, Useful when oral acid-suppressing medicine cannot be used, May help manage reflux oesophagitis and hypersecretory acid conditions under medical care |
| Primary Uses | Gastric ulcer, Duodenal ulcer, Reflux oesophagitis, Zollinger-Ellison syndrome, Short-term alternative to oral omeprazole when oral therapy is inappropriate |
| Drug Class | Proton pump inhibitor |
| Indications | Used for acid-related gastrointestinal disorders such as gastric ulcer, duodenal ulcer, reflux oesophagitis and Zollinger-Ellison syndrome when intravenous therapy is considered appropriate by a healthcare professional. |
| Used For | Reduction of stomach acid in selected acid-related gastrointestinal conditions. |
| Suitable For | Patients who require omeprazole therapy and cannot use oral treatment, as determined by a healthcare professional. |
| Who Itu2019s For | For patients prescribed injectable omeprazole by a doctor, usually in a hospital, clinic or supervised healthcare setting. |
| How It Works | Omeprazole inhibits the gastric proton pump in stomach parietal cells, reducing the final step of acid secretion and lowering gastric acidity. |
| Therapeutic Category | Anti-ulcerant / gastric acid suppression therapy |
| Marketer / Distributor | English Pharma |
| Country of Origin | Pakistan |
| Prescription Required | Yes |
| Recommended Dose | Dose must be prescribed by a doctor. A commonly used adult dose for many acid-related indications is 40mg once daily when oral therapy is inappropriate, but dosing may vary by condition and patient response. |
| How to Use | For intravenous injection or infusion only, prepared and administered by a qualified healthcare professional according to clinical protocol and product instructions. |
| When to Take | Administer at the time and frequency prescribed by the doctor. Timing may depend on the clinical condition and treatment plan. |
| Maximum Daily Dose | Do not exceed the dose prescribed by the doctor. Higher doses for hypersecretory conditions require specialist supervision. |
| Age Group | Use as prescribed; adult use is common. Pediatric use should be determined by a specialist. |
| Pediatric Use | Limited pediatric use should be guided by a qualified healthcare professional. Do not use in children unless prescribed. |
| Adult Dose | Commonly 40mg once daily when oral therapy is not suitable, unless the prescriber recommends a different regimen. |
| Elderly Use | Dose adjustment is generally not required solely because of age, but elderly patients should use it under medical supervision with attention to overall health and other medicines. |
| Missed Dose | Because this medicine is administered by healthcare professionals, missed doses should be handled by the treating doctor or nurse. Do not double a dose without medical advice. |
| Overdose Instructions | In case of suspected overdose or accidental administration error, seek urgent medical attention and provide the medicine details to healthcare staff. |
| Before or After Food | Food timing is usually not relevant for intravenous administration, but follow the prescriber’s instructions. |
| Administration Instructions | Intravenous injection or infusion by trained healthcare personnel only. Not for self-administration. |
| Warnings | Use only on prescription and under medical supervision., Do not use if allergic to omeprazole, other proton pump inhibitors or substituted benzimidazoles., Tell your doctor about alarm symptoms such as unexplained weight loss, vomiting blood, black stools or difficulty swallowing., Longer-term proton pump inhibitor use may require monitoring for low magnesium, vitamin B12 deficiency, bone fracture risk or gastrointestinal infections. |
| Precautions | Inform the doctor about liver disease, kidney problems, pregnancy, breastfeeding and all current medicines., Review the need for injectable therapy regularly and switch to oral treatment when clinically appropriate., Do not mix or administer with other products unless compatibility is confirmed. |
| Contraindications | Known hypersensitivity to omeprazole, substituted benzimidazoles or any component of the formulation. |
| When Not to Use | Do not use if the patient has a known allergy to omeprazole or related proton pump inhibitors. Do not use without a valid medical prescription. |
| Allergy Warning | Seek urgent help if signs of allergy occur, including rash, itching, swelling of the face or throat, severe dizziness, wheezing or difficulty breathing. |
| Common Side Effects | Headache, Abdominal pain, Nausea, Vomiting, Diarrhoea, Constipation, Flatulence, Dizziness |
| Serious Side Effects | Severe allergic reaction, Severe or persistent diarrhoea, Severe skin reaction, Signs of liver problems such as yellowing of skin or eyes, Symptoms of low magnesium during prolonged use such as seizures, irregular heartbeat or muscle spasms |
| Pregnancy Warning | Use during pregnancy only if prescribed by a healthcare professional after assessing benefit and risk. |
| Breastfeeding Warning | Consult a doctor before use while breastfeeding. The prescriber should decide whether treatment is appropriate. |
| Fertility Warning | No product-specific fertility guidance is confirmed for this listing. Discuss concerns with a healthcare professional. |
| Liver Warning | Use with medical supervision in patients with liver disease; dose adjustment or monitoring may be required depending on clinical status. |
| Kidney Warning | Use under medical advice in patients with kidney disease, especially if symptoms change or other medicines are being used. |
| Heart Warning | Patients with heart disease or those taking medicines such as clopidogrel, warfarin or digoxin should inform their doctor before treatment. |
| Driving or Machine Use Warning | Omeprazole is not expected to impair driving in most patients, but dizziness or visual disturbance may occur. Do not drive or operate machinery if affected. |
| Alcohol Warning | Alcohol may worsen gastric irritation or reflux symptoms. Follow medical advice and avoid alcohol if it aggravates symptoms. |
| Drug Interactions | Clopidogrel, Warfarin, Diazepam, Phenytoin, Digoxin, Methotrexate, Tacrolimus, Certain antifungal medicines such as ketoconazole or itraconazole, Certain HIV medicines, Medicines affected by stomach acidity or CYP2C19 metabolism |
| Food Interactions | No major food interaction is expected with intravenous administration, but diet may influence reflux or ulcer symptoms. Follow the clinician’s dietary advice. |
| Disease Interactions | Liver disease, Suspected gastric malignancy or alarm gastrointestinal symptoms, History of low magnesium with prolonged acid suppression, Osteoporosis or high fracture risk with long-term proton pump inhibitor use |
| Storage Instructions | Store in the original packaging according to the label instructions. Protect from excessive heat, light and moisture. Use prepared solution within the recommended period set by product information or facility protocol. |
| Disposal Instructions | Dispose of unused medicine, vials, needles and clinical waste according to hospital, pharmacy or local healthcare waste procedures. |
| Keep Away From Children | Keep out of the reach and sight of children. |
| Temperature Requirement | Follow the storage temperature stated on the product label; do not freeze unless specifically instructed. |
| Disclaimer | This information is for educational and product listing purposes only and is not a substitute for professional medical advice. Use only as prescribed and administered by qualified healthcare professionals. Consult a doctor or pharmacist for diagnosis, dosing, interactions, pregnancy or breastfeeding advice, side effects or emergencies. |
All In One Medicine policy reference: Shipping Policy | Return Policy | Refund Policy
This product may be fulfilled through the source shown below. Source fees, delivery coverage, payment limits, return windows, and refund routes can be stricter than ordinary ecommerce because medicines, prescriptions, cold-chain items, baby products, hygiene goods, and opened products have safety limits.
This product may be fulfilled through more than one source. The applicable delivery, payment, return, and refund rule depends on which source ships the item. Source sections shown below: Health Wire, Ailaaj.
Shipping & Delivery - Health Wire
Delivery, return, and refund handling
- Healthwire routes medicine orders to the dispensing partner pharmacy that accepts the order.
- Services are restricted to selected territories within Pakistan.
- Prescription medicine ordering is restricted to customers aged 18 or older.
- Delivery time, courier choice, delivery fee, and serviceability are set by the dispensing partner pharmacy and confirmed at order time.
- Healthwire does not publish one unified shipping or return policy for all pharmacy orders.
- The return and refund terms for a medicine order are the actual dispensing partner pharmacy terms.
- Standard pharmacy restrictions still apply to opened, used, prescription, hygiene-sensitive, and temperature-sensitive products.
Shipping & Delivery - Ailaaj
Shipping scope and dispatch notes
- Ailaaj states delivery is for Pakistan addresses only, while orders can be placed from abroad if the delivery address is in Pakistan.
- Its terms state delivery charges vary by city and are shown at order booking/checkout.
- Delivery timing is courier-dependent and can vary by location and product type.
- Prescription medicines and controlled medicines require valid prescription verification before shipment.
Cancellation, return, and refund notes
- Published policy states an order cannot be edited after order ID generation, but cancellation is allowed before payment is processed.
- Ailaaj states damaged, incomplete, or incorrect deliveries should be reported within 24 hours of receipt.
- Cold-chain items are stated as non-cancellable after shipping and generally non-returnable/non-refundable except wrong-item replacement cases.
- The return page states refunds may be issued as store credit after policy checks and applicable deductions; it also states no cash refund.
- Its terms also state refund flow depends on payment channel and timing.
Related products
-
From: DVAGO
Relnorm Tablets 25Mg (1 Strip = 10 Tablets)
₨ 190Original price was: ₨ 190.₨ 181Current price is: ₨ 181.Add to cart -
From: DVAGO
Humalog Mix 25 Kwikpen Injection 100U/Ml (1 Box = 5 Injection)
₨ 2,117Original price was: ₨ 2,117.₨ 2,011Current price is: ₨ 2,011.Add to cart -
From: DVAGO
Zn Plus Shampoo 100Ml
₨ 349Original price was: ₨ 349.₨ 332Current price is: ₨ 332.Add to cart -
From: DVAGO
Vidaylin T Tablets (1 Bottle = 30 Tablets)
₨ 280Original price was: ₨ 280.₨ 266Current price is: ₨ 266.Add to cart -
From: DVAGO
Ringolact Infusion 1000Ml
₨ 170Original price was: ₨ 170.₨ 162Current price is: ₨ 162.Add to cart







Reviews
There are no reviews yet.